Gentian Diagnostics ASA (GENT.OL)

Oslo Børs · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Gentian Diagnostics ASA reported revenue of NOK 152.1M and net income of NOK 45.3M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

NOK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	NOK 152.1M	NOK 135.2M	NOK 101.6M	NOK 83.1M	NOK 63.3M
Gross profit	NOK 82.8M	NOK 64.2M	–	–	–
Operating income	NOK 15.7M	−NOK 12.8M	−NOK 23.2M	−NOK 22.8M	−NOK 17.8M
Net income	NOK 45.3M	−NOK 10.6M	NOK 45.3M	−NOK 24.8M	−NOK 17.5M
Diluted EPS	NOK 2.87	−NOK 0.69	−NOK 1.53	−NOK 1.61	−NOK 1.13
Cash flow
Operating cash flow	NOK 13.5M	NOK 15.5M	−NOK 14.0M	−NOK 27.1M	−NOK 12.5M
Capital expenditure	NOK 1.4M	NOK 955.0K	NOK 8.6M	NOK 1.0M	NOK 2.7M
Free cash flow	NOK 12.1M	NOK 14.5M	−NOK 22.6M	−NOK 28.1M	−NOK 15.2M
Balance sheet
Cash and equivalents	NOK 84.7M	NOK 87.6M	NOK 81.6M	NOK 114.9M	NOK 158.0M
Total assets	NOK 229.7M	NOK 181.0M	NOK 187.8M	NOK 211.8M	NOK 235.3M
Total liabilities	NOK 35.6M	NOK 34.4M	NOK 33.6M	NOK 37.0M	NOK 40.7M
Shareholders' equity	NOK 194.1M	NOK 146.6M	NOK 154.2M	NOK 174.8M	NOK 194.6M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full GENT.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open GENT.OL financials →